middl
east
respiratori
syndrom
coronaviru
merscov
recent
emerg
viru
caus
number
human
infect
death
primarili
middl
east
transmiss
merscov
human
propos
result
contact
camel
evid
humantohuman
transmiss
also
exist
order
work
merscov
laboratori
set
us
center
diseas
control
prevent
cdc
determin
merscov
handl
biosafeti
level
bsl
biocontain
level
mani
process
procedur
use
character
merscov
evalu
sampl
merscov
infect
anim
easili
effici
complet
lower
contain
order
complet
experiment
work
demonstr
proof
inactiv
requir
remov
specimen
biocontain
laboratori
studi
present
evalu
typic
mean
inactiv
virus
prior
handl
specimen
lower
biocontain
level
found
trizol
avl
buffer
gamma
irradi
effect
inactiv
merscov
formaldehydebas
solut
requir
least
minut
contact
time
cell
cultur
system
mixtur
methanol
aceton
requir
minut
inactiv
merscov
togeth
data
provid
foundat
safe
inactiv
merscov
potenti
coronavirus
prior
remov
biocontain
facil
standard
cell
cultur
fixat
protocol
suffici
inactiv
merscov
use
trizol
avl
similar
reagent
complet
effect
inactiv
merscov
dose
mrad
use
co
sourc
inactiv
merscov
positivesens
rna
isol
merscov
infect
cell
contain
viabl
viru
infecti
kumar
et
al
fall
emerg
identif
novel
sarslik
coronaviru
middl
east
rais
intern
concern
possibl
viral
epidem
pandem
subsequ
signific
amount
effort
put
toward
develop
vaccin
antivir
anim
model
becam
known
middl
east
respiratori
syndromecoronaviru
merscov
envelop
viru
positivesens
rna
genom
sinc
initi
emerg
jordan
april
viru
becom
signific
health
concern
throughout
middl
east
particularli
saudi
arabia
viru
isol
first
identifi
june
corman
et
al
hijawi
et
al
zaki
et
al
juli
laboratori
confirm
case
merscov
infect
least
death
associ
infect
viru
global
alert
respons
websit
http
wwwwhointcsrdonen
major
case
occur
saudi
arabia
sinc
discoveri
consider
effort
put
toward
determin
anim
reservoir
merscov
also
develop
experiment
anim
model
mimic
human
diseas
effort
identifi
camel
potenti
reservoir
merscov
azhar
et
al
hemida
et
al
evalu
potenti
anim
model
found
mice
hamster
ideal
model
de
wit
et
al
macaqu
develop
rel
mild
selflimit
infect
de
wit
et
al
order
complet
mani
field
model
develop
studi
inactiv
merscov
critic
activ
allow
safe
test
materi
potenti
contain
merscov
unit
state
center
diseas
control
prevent
cdc
determin
propag
laboratori
character
merscov
perform
biosafeti
level
bsl
laboratori
due
risk
aerosol
transmiss
appar
high
case
fatal
rate
guidelin
add
number
restrict
movement
subsequ
work
materi
gener
facil
typic
mani
downstream
studi
perform
highli
pathogen
virus
complet
laboratori
space
due
avail
equip
reduc
stress
staff
order
complet
work
safe
virus
must
inactiv
prior
remov
high
contain
laboratori
previou
studi
close
relat
sarscoronaviru
establish
treatment
viru
heat
ultraviolet
light
chemic
inactiv
varieti
deterg
effect
inactiv
betacoronavirus
darnel
et
al
darnel
taylor
kariwa
et
al
leclercq
et
al
rabenau
et
al
rabenau
et
al
leclercq
et
al
shown
heat
effect
inactiv
merscov
leclercq
et
al
studi
describ
test
five
typic
viru
inactiv
method
would
allow
downstream
analysi
merscov
infect
outsid
high
contain
laboratori
method
includ
inactiv
trizol
avl
buffer
rna
analys
formalinparaformaldehyd
treatment
fixat
cell
cell
cultur
plate
mixtur
methanol
aceton
fixationpermeabil
cell
gamma
irradi
inactiv
viru
cell
cultur
tissu
sampl
found
gamma
irradi
trizol
avl
inactiv
method
consist
effect
fixat
cell
cultur
sampl
clearli
time
depend
vari
fixat
method
merscov
jordan
strain
courtesi
dr
kanta
subbarao
niaid
bethesda
md
gabriel
defang
cairo
egypt
use
studi
present
viru
cultiv
vero
atcc
vero
atcc
maintain
dmem
lonza
supplement
fb
cell
atcc
maintain
emem
lonza
fb
cell
kept
co
incub
neither
antibiot
antimycot
use
mainten
cell
vero
cell
plate
plate
densiti
cellswel
ensur
least
confluenc
follow
day
tenfold
serial
dilut
merscov
ad
duplic
individu
well
viru
allow
infect
cell
co
rock
everi
minut
cell
overlaid
tragacanth
dilut
fc
emem
qualiti
biolog
contain
fb
incub
co
day
overlay
remov
cell
fix
crystal
violet
nbf
room
temperatur
rt
plate
wash
water
plaqu
enumer
viru
stock
tube
contain
either
pfuml
ml
volum
irradi
specifi
dose
use
jl
shepherd
cobalt
co
sourc
use
rotat
stage
ensur
even
irradi
viru
stock
maintain
dri
ice
entir
cours
irradi
process
determin
viabil
complet
plaqu
assay
duplic
sampl
cell
cultur
supernat
titer
pfuml
inactiv
volum
trizol
ls
accord
manufactur
instruct
mixtur
incub
min
room
temperatur
remov
trizol
use
amicon
ultra
kda
nmwl
centrifug
concentr
trizol
viru
solut
ad
concentr
centrifug
min
concentr
dilut
pb
centrifug
min
concentr
dilut
dmem
centrifug
minut
concentr
invert
clean
tube
centrifug
min
collect
concentr
concentr
dialysi
procedur
also
perform
viru
stock
treat
trizol
determin
loss
viru
concentrationdialysi
procedur
concentr
materi
ad
vero
cell
flask
incub
co
day
posit
neg
control
flask
also
inocul
follow
incub
period
cell
cultur
supernat
remov
clarifi
ad
fresh
flask
vero
cell
cell
subsequ
incub
co
day
cell
cultur
supernat
collect
clarifi
subject
immunofluoresc
assay
ifa
fresh
vero
cell
use
method
describ
duplic
sampl
cell
cultur
supernat
initi
titer
pfuml
treat
avl
buffer
qiagen
ratio
supernat
incub
room
temperatur
min
ethanol
ad
final
volum
vortex
mixtur
transfer
amicon
centrifug
concentr
process
residu
titer
determin
plaqu
assay
day
inocul
flask
seed
vero
cell
cell
ensur
confluenc
day
inocul
day
inocul
media
remov
flask
cell
infect
merscov
multipl
infect
moi
complet
media
mock
sampl
also
prepar
cell
type
media
sampl
incub
co
rock
everi
minut
one
hour
one
hour
incub
complet
media
ad
flask
incub
co
hour
hour
post
infect
media
collect
flask
transfer
conic
one
infect
flask
cell
type
serv
posit
control
sampl
dilut
inocul
control
flask
next
passag
media
second
infect
flask
combin
trizol
ls
life
technolog
ratio
recommend
manufactur
incub
min
rt
inactiv
viru
total
rna
subsequ
extract
follow
manufactur
protocol
http
toolslifetechnologiescomcontentsfsmanualstrizollsreagentpdf
rna
extract
merscov
infect
vero
cell
brought
media
use
inocul
flask
cell
type
posit
merscov
stock
dilut
neg
media
control
includ
vero
cell
follow
inocul
flask
incub
minut
rock
minut
minut
media
ad
flask
subsequ
incub
co
hour
posit
control
cell
began
show
cytopath
effect
cpe
day
inocul
dish
seed
vero
cell
per
dish
ensur
confluenc
day
inocul
day
inocul
estim
cell
count
use
calcul
cell
per
dish
media
remov
dish
cell
infect
merscov
moi
inoculum
duplic
mock
infect
sampl
also
prepar
duplic
media
lonza
dmem
fb
sampl
incub
co
rock
everi
minut
one
hour
one
hour
incub
media
ad
dish
incub
co
hour
hour
post
infect
media
remov
dish
posit
unfix
neg
uninfect
control
dish
wash
three
time
pb
resuspend
scrape
pb
aliquot
clean
tube
cell
remain
dish
fix
follow
duplic
neutral
buffer
formalin
nbf
fisher
scientif
minut
minut
minut
paraformaldehyd
pfa
freshli
made
pfa
stock
concentr
electron
microscopi
scienc
minut
minut
minut
methanol
aceton
minut
minut
minut
minut
time
point
fix
remov
cell
wash
pb
resuspend
scrape
pb
order
demonstr
inactiv
viru
viru
sampl
blind
passag
twice
vero
cell
supernat
final
passag
test
presenc
viabl
viru
use
cell
cultur
base
immunofluoresc
assay
ifa
first
serial
passag
flask
seed
vero
cell
ensur
confluenc
day
inocul
media
remov
flask
replac
test
inoculum
posit
dilut
viru
stock
neg
control
also
use
inocul
flask
seed
densiti
flask
incub
minut
rock
minut
minut
media
ad
flask
left
incub
co
day
day
media
flask
remov
centrifug
min
remov
cell
debri
supernat
transfer
fresh
flask
seed
day
prior
flask
incub
co
day
cell
photograph
end
passag
document
visibl
cpe
figur
cell
cultur
supernat
remov
clarifi
centrifug
minut
supernat
remov
test
presenc
viru
use
ifa
test
sampl
serial
dilut
tenfold
ifa
inoculum
addit
blind
passag
sampl
includ
ifa
neg
control
complet
media
ifa
posit
control
dilut
viru
stock
onehundr
microlit
specifi
inoculum
ad
well
well
plate
greiner
bioon
seed
day
vero
cell
per
well
incub
hour
co
hr
plate
fix
ad
nbf
final
concentr
nbf
incub
minut
rt
nbf
remov
replac
fresh
nbf
incub
hour
follow
previous
establish
safeti
protocol
fix
plate
wash
four
time
pb
permeabil
permeabil
solut
triton
pb
sigma
minut
rt
cell
wash
four
time
block
normal
goat
serum
vector
lab
pb
hour
rt
thirti
microlit
rabbit
polyclon
antibodi
novel
coronaviru
spike
protein
sino
biolog
dilut
normal
goat
serum
pb
ad
well
plate
rock
hour
rt
wash
five
time
pb
antirabbit
alexafluor
invitrogen
dilut
pb
ad
well
plate
cover
foil
rock
minut
rt
follow
four
wash
pb
nuclear
counterstain
cell
incub
hoechst
life
technolog
dilut
pb
min
rt
wash
twice
pb
pb
ad
well
prevent
cell
dri
data
collect
operetta
high
content
imag
system
perkin
elmer
imag
taken
use
long
wd
object
nine
field
per
well
plate
account
main
compon
quantit
analysi
use
harmoni
imag
analysi
softwar
total
number
cell
base
nuclear
stain
number
cell
infect
merscov
base
intens
alexa
fluoresc
threshold
cytoplasm
region
ratio
total
number
cell
fluoresc
cell
determin
percentag
cell
posit
merscov
use
gamma
irradi
co
sourc
common
facil
due
expens
gamma
sourc
instrument
avail
laboratori
number
newer
facil
lower
energi
cs
sourc
often
found
within
hospit
set
irradi
blood
blood
product
lower
energi
provid
practic
timefram
inactiv
virus
gamma
irradi
also
provid
mean
translat
inactiv
protocol
institut
effect
dose
rad
consist
instrument
necessarili
user
depend
kinet
merscov
inactiv
gamma
irradi
evalu
use
viru
stock
typic
titer
log
concentr
viru
stock
log
viru
stock
irradi
specifi
dose
result
titer
quantifi
studi
found
mrad
suffici
reduc
titer
log
mrad
suffici
complet
inactiv
viru
determin
plaqu
assay
figur
data
suggest
radiat
dose
least
mrad
suffici
inactiv
merscov
laboratori
cell
cultur
tissuebas
assay
use
trizol
trizol
ls
typic
isol
purif
rna
dna
virusinfect
cell
cell
cultur
supernat
combin
guanidin
isothiocyan
phenol
proven
effect
inactiv
envelop
virus
blow
et
al
use
mani
year
isol
viral
dna
rna
biolog
virolog
analysi
studi
viru
stock
pfuml
mix
trizol
ls
ratio
follow
manufactur
recommend
procedur
given
toxic
trizol
ls
cultur
cell
rna
extract
trizol
ls
treat
materi
prior
inocul
fresh
cell
follow
blind
passag
treat
materi
found
treatment
trizol
ls
complet
effect
inactiv
merscov
figur
follow
minut
rt
incub
use
concentr
remov
residu
trizol
ls
effect
effici
use
standard
dialysi
approach
loss
log
viru
seen
figur
untreat
control
sampl
addit
fact
evid
viru
product
also
indic
purifi
rna
merscov
positivesens
rna
viru
infecti
use
avl
buffer
replac
use
trizol
ls
mani
applic
isol
viral
rna
desir
avlbas
extract
system
effici
autom
elimin
need
use
organ
solvent
order
demonstr
treatment
merscov
contain
cell
cultur
supernat
effect
inactiv
viru
slightli
modifi
version
protocol
distribut
qiaamp
viral
rna
isol
kit
use
follow
inactiv
serial
passag
cell
cultur
supernat
viru
evid
test
materi
posit
control
treat
similar
manner
less
use
avl
titer
pfuml
tabl
use
nbf
pfa
common
practic
fixat
viru
infect
cell
tissu
variou
assay
includ
plaqu
assay
focu
form
assay
histolog
studi
order
determin
effect
nbf
pfa
inactiv
merscov
cell
cultur
set
infect
cell
fix
specifi
period
time
wash
use
infect
fresh
cell
two
serial
blind
passag
cell
cultur
supernat
second
passag
test
presenc
viru
use
cellbas
immunofluoresc
assay
establish
evalu
merscov
infect
dyall
et
al
duplic
sampl
found
incub
either
new
commerci
provid
nbf
freshli
prepar
pfa
minut
ineffect
complet
inactiv
merscov
found
incub
nbf
minut
complet
inactiv
merscov
minut
treatment
pfa
requir
tabl
given
nbf
pfa
chemic
similar
except
nbf
contain
methanol
minimum
minut
incub
time
rt
either
reagent
would
prudent
ensur
complet
inactiv
merscov
cell
cultur
set
inactiv
merscov
tissu
determin
mixtur
methanol
aceton
frequent
use
fixat
permeabil
cell
immunostain
techniqu
effort
avoid
crosslink
protein
antigen
epitop
loss
occur
use
aldehydebas
fix
thavarajah
et
al
test
abil
inactiv
merscov
infect
cultur
cell
would
typic
ifatyp
assay
studi
found
partial
effect
use
minut
fixat
effect
longer
fixat
time
tabl
data
suggest
minimum
minut
fixat
time
use
inactiv
merscov
infect
cell
cultur
system
mani
academ
govern
industri
set
posit
demonstr
viru
inactiv
becom
common
requir
prior
remov
materi
biocontain
laboratori
shipment
materi
collabor
test
purpos
divis
select
agent
toxin
also
indic
demonstr
viru
inactiv
provis
clearli
defin
method
demonstr
viru
inactiv
incorpor
safeti
program
pathogen
light
test
recent
emerg
merscov
use
variou
typic
inactiv
method
valid
standard
procedur
suffici
inactiv
merscov
found
frequent
use
inactiv
method
nbf
pfa
trizol
ls
perform
expect
complet
inactiv
merscov
within
nbfpfa
trizol
lsavl
minut
use
gamma
irradi
shown
render
log
merscov
undetect
plaqu
assay
follow
dose
publish
penetr
rate
formalin
suggest
rate
hour
medawar
howev
rate
penetr
tissu
cell
simpl
linear
process
depend
upon
tissu
composit
cell
type
addit
necessari
aldehyd
crosslink
requir
inactiv
viru
particl
independ
chemic
penetr
rate
evalu
process
blind
passag
harvest
cell
requir
viru
particl
prepar
adequ
inactiv
nbf
freshli
prepar
pfa
similar
chemic
surpris
find
one
replic
pfa
treatment
complet
inactiv
merscov
minut
incub
one
replic
pfa
replic
nbf
complet
effect
treatment
minut
shown
univers
effect
nbf
pfa
adopt
minimum
standard
inactiv
merscov
infect
cultur
cell
use
mixtur
methanol
aceton
typic
often
use
fix
permeabil
cell
immunoassay
ifa
microscopi
techniqu
found
mixtur
suffici
inactiv
merscov
infect
cell
room
temperatur
incub
least
minut
techniqu
effect
inactiv
viru
use
evalu
cellular
morpholog
care
consid
due
gener
cellular
artifact
moloney
et
al
trizol
inactiv
virus
purpos
extract
viral
dna
rna
standard
methodolog
mani
year
combin
activ
phenol
compon
disrupt
membran
denatur
protein
addit
power
denatur
activ
guanidin
isothiocyan
make
reagent
effect
inactiv
envelop
virus
despit
likelihood
trizol
inactiv
viru
cell
cultur
supernat
infect
cell
within
second
standard
methodolog
dictat
minimum
minut
room
temperatur
incub
ensur
inactiv
reagent
avl
buffer
reli
primarili
guanidin
isothiocyan
denatur
inactiv
virus
use
frequent
research
lab
field
work
due
eas
transport
abil
autom
easier
use
dispos
work
shown
clearli
demonstr
merscov
natur
infecti
cell
cultur
system
abil
posit
strand
viral
rna
infect
cultur
cell
point
content
number
year
nih
offic
biotecnolog
activ
oba
recombin
dna
advisori
committe
suggest
purifi
fulli
intact
rna
posit
strand
virus
handl
biocontain
level
pathogen
question
data
inactiv
merscov
trizol
ls
subsequ
addit
cultur
cell
demonstr
purifi
rna
viru
infect
cultur
cell
suggest
guidanc
oba
appropri
viru
use
gamma
irradi
likewis
use
mani
year
inactiv
virus
doubt
irradi
inactiv
virus
requir
kill
dose
valuabl
inform
irradi
time
get
long
particularli
age
gamma
sourc
increas
also
question
thermal
impact
viru
stock
experiment
sampl
heat
gener
within
gamma
cell
signific
advers
affect
materi
care
control
found
complet
inactiv
log
cell
cultur
stock
achiev
follow
dose
co
sourc
sampl
held
dri
ice
l
nalgen
beaker
cours
irradi
clearli
effect
mrad
appreci
mrad
suffici
inactiv
merscov
prudent
level
caution
facil
recommend
util
minimum
mrad
inactiv
merscov
cell
cultur
supernat
irradi
condit
dose
also
suffici
viru
collect
biolog
system
includ
tissu
work
describ
test
seri
procedur
frequent
use
inactiv
envelop
virus
laboratori
set
abil
render
merscov
noninfecti
procedur
use
fixat
infect
cell
prepar
materi
dna
rna
analysi
irradi
sampl
assay
antibodi
cytokin
analysi
techniqu
shown
inactiv
merscov
critic
time
compon
must
met
data
provid
serv
guidelin
research
demonstr
viru
inactiv
determin
empir
individu
investig
particularli
regard
use
fix
inactiv
virus
procedur
heavili
depend
upon
user
requir
qualiti
reagent
irradi
inactiv
curv
merscov
two
differ
stock
merscov
irradi
mrad
co
gamma
sourc
aliquot
stock
titrat
plaqu
assay
determin
residu
viru
titer
data
point
averag
duplic
aliquot
inactiv
merscov
avl
buffer
fix
b
